Literature DB >> 4810906

Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.

V V Likhite, B N Halpern.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4810906

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  12 in total

1.  Characterization of mouse peritoneal exudate and associated leukocyte adherence inhibitory activity after intraperitoneal injection of either Bordetella pertussis or Corynebacterium parvum vaccines.

Authors:  T W Klein; S H Pross; W R Benjamin
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

2.  Adjuvant treatment of colorectal cancer.

Authors:  J S Nystrom; J R Bateman; J Weiner
Journal:  West J Med       Date:  1977-02

Review 3.  Prospects for the therapeutic use of anticancer vaccines.

Authors:  R S Chamberlain
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

4.  Effects of Propionibacterium acnes treatment on the course of Mycobacterium leprae infection in mice.

Authors:  J L Krahenbuhl; R C Humphres; P C Henika
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

5.  The growth and spontaneous dissemination of melanoma B16 and Lewis lung tumour in two sub-strains of C57BL/6J mice treated with Corynebacterium parvum and/or levamisole.

Authors:  B Boeryd; A Benktson
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

6.  Nitric oxide is an important mediator for tumoricidal activity in vivo.

Authors:  R Farias-Eisner; M P Sherman; E Aeberhard; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells.

Authors:  J L Krahenbuhl; L H Lambert; J S Remington
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

8.  Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.

Authors:  M F Woodruff; N Dunbar
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

9.  Complement activation in vivo in cancer patients receiving C. parvum immunotherapy.

Authors:  H Biran; J L Moake; R C Reed; J U Gutterman; E M Hersh; E J Freireich; G M Mavligit
Journal:  Br J Cancer       Date:  1976-11       Impact factor: 7.640

10.  Radiolabelling of Corynebacterium parvum and its distribution in mice.

Authors:  T E Sadler; W A Cramp; J E Castro
Journal:  Br J Cancer       Date:  1977-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.